Cameron Callaghan

Has grant

Assistant Professor

Mayo Clinic

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Cameron Callaghan is an Assistant Professor at the Mayo Clinic in the United States. His research focuses on the application of advanced radiotherapy techniques, particularly in the context of cancer treatment, with recent publications addressing topics such as DNA-PK inhibition, proton therapy optimization, and the potential of tumor-derived extracellular vesicles as biomarkers. His work aims to enhance therapeutic strategies in various malignancies including rectal cancer and pancreatic adenocarcinoma.

Recent Grants

Grant: Close

New personalized photon and particle radiotherapy strategies to overcome therapeutic resistance

Open Date: 2023-06-01

Close Date:

Grant: Close

Pharmacologic Ascorbate Combined with DNA Repair Inhibitors Enhances the Therapeutic Index of Radiation Therapy

Open Date: 2020-06-01

Close Date: 2021-06-01

Articles (17)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (5)

Mitchell C. Coleman

UNITED STATES

View details

Steven Seyedin

Assitant Professor

University of California Irvine Medical Center

UNITED STATES

View details

Prabhat Goswami

University of Iowa Hospitals and Clinics

UNITED STATES

View details

Bryan Allen

Associate Professor / Physician Scientist

University of Iowa Healthcare

UNITED STATES

View details

Vincent Ho

Associate Professor

University of Western Sydney

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Cameron Callaghan

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (17)

DNA-PK Inhibition Shows Differential Radiosensitization in Orthotopic GBM PDX Models Based on DDR Pathway Deficits

Linear energy transfer optimized proton therapy for rectal cancer

Linear energy transfer optimized proton therapy for rectal cancer

Poly ADP ribose polymerase inhibitors potentiate proton therapy end-of-range relative biological effective dose by increasing replication stress

Tumor-derived extracellular vesicles: A potential novel liquid biomarker for pancreatic ductal adenocarcinoma

Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis Xenografts

DNA-PK Inhibition Shows Differential Radiosensitization in Orthotopic GBM PDX Models Based on DDR Pathway Deficits

Proton Stereotactic Body Radiotherapy for Liver Metastases From Malignant Pancreatic Insulinoma

The Role of Destrin Wnt/β-Catenin Signaling Pathway in Rectal Cancer Oncogenesis

Resection of a Solitary Right Ventricular Metastasis in Oligorecurrent Hepatocellular Carcinoma

Manipulation of Redox Metabolism Using Pharmacologic Ascorbate Opens a Therapeutic Window for Radio-Sensitization by ATM Inhibitors in Colorectal Cancer.

Assessment of gadobutrol safety in combination with ionizing radiation using a preclinical MRI-guided radiotherapy model

Combination Therapy with Radiation and PARP Inhibition Enhances Responsiveness to Anti-PD-1 Therapy in Colorectal Tumor Models

Neoadjuvant Radiotherapy-Related Wound Morbidity in Soft Tissue Sarcoma: Perspectives for Radioprotective Agents.

The Effect of Concurrent Stereotactic Body Radiation and Anti-PD-1 Therapy for Recurrent Metastatic Sarcoma.

The Effect of Concurrent Stereotactic Body Radiation and Anti-PD-1 Therapy for Recurrent Metastatic Sarcoma

Brachytherapy Future Directions.

Collaborators (5)

Mitchell C. Coleman

Steven Seyedin

Prabhat Goswami

Bryan Allen

Vincent Ho

Make your next move.